Whitehawk Therapeutics (WHWK) Retained Earnings (2018 - 2025)
Historic Retained Earnings for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to -$330.0 million.
- Whitehawk Therapeutics' Retained Earnings fell 496.18% to -$330.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$330.0 million, marking a year-over-year decrease of 496.18%. This contributed to the annual value of -$332.7 million for FY2024, which is 2368.02% down from last year.
- Latest data reveals that Whitehawk Therapeutics reported Retained Earnings of -$330.0 million as of Q3 2025, which was down 496.18% from -$312.3 million recorded in Q2 2025.
- Whitehawk Therapeutics' 5-year Retained Earnings high stood at -$126.7 million for Q3 2021, and its period low was -$332.7 million during Q4 2024.
- Moreover, its 5-year median value for Retained Earnings was -$236.4 million (2023), whereas its average is -$232.3 million.
- Per our database at Business Quant, Whitehawk Therapeutics' Retained Earnings surged by 1066.97% in 2021 and then plummeted by 4940.81% in 2022.
- Whitehawk Therapeutics' Retained Earnings (Quarter) stood at -$142.7 million in 2021, then crashed by 42.41% to -$203.2 million in 2022, then tumbled by 32.36% to -$269.0 million in 2023, then decreased by 23.68% to -$332.7 million in 2024, then rose by 0.8% to -$330.0 million in 2025.
- Its last three reported values are -$330.0 million in Q3 2025, -$312.3 million for Q2 2025, and -$259.6 million during Q1 2025.